SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010973
Filing Date
2021-08-09
Accepted
2021-08-09 16:12:06
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20210630x10q.htm   iXBRL 10-Q 1724759
2 EX-31.1 idra-20210630xex31d1.htm EX-31.1 14058
3 EX-31.2 idra-20210630xex31d2.htm EX-31.2 13768
4 EX-32.1 idra-20210630xex32d1.htm EX-32.1 7140
5 EX-32.2 idra-20210630xex32d2.htm EX-32.2 7749
6 GRAPHIC idra-20210630x10q004.jpg GRAPHIC 7407
7 GRAPHIC idra-20210630x10q012.jpg GRAPHIC 4117
8 GRAPHIC idra-20210630x10q013.jpg GRAPHIC 3734
  Complete submission text file 0001558370-21-010973.txt   7395455

Data Files

Seq Description Document Type Size
9 EX-101.SCH idra-20210630.xsd EX-101.SCH 47892
10 EX-101.CAL idra-20210630_cal.xml EX-101.CAL 39323
11 EX-101.DEF idra-20210630_def.xml EX-101.DEF 184520
12 EX-101.LAB idra-20210630_lab.xml EX-101.LAB 406504
13 EX-101.PRE idra-20210630_pre.xml EX-101.PRE 346718
14 EXTRACTED XBRL INSTANCE DOCUMENT idra-20210630x10q_htm.xml XML 1463822
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 211156610
SIC: 2836 Biological Products, (No Diagnostic Substances)